REGENSBURG, GERMANY--(Marketwire - November 10, 2008) - Regensburg, November 10, 2008 - GENEART AG, global leader in gene synthesis and specialist in the field of Synthetic Biology, announces the successful conclusion of its project with the US National Cancer Institute (part of the National Institutes of Health) in regard to the “Mammalian Gene Collection” (MGC) today.
